Loratadine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
A second-generation antihistamine with minimal sedative effects, used for the symptomatic relief of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. One of the least sedating oral antihistamines due to very limited CNS penetration. Available over-the-counter and widely used for its favorable tolerability profile. Active metabolite desloratadine (Clarinex) is also marketed separately.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
A second-generation antihistamine with minimal sedative effects, used for the symptomatic relief of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. NutriStack rates the supporting evidence as strong. Common adult dosing is Adults and children >=6 years: 10 mg once daily; children 2-5 years: 5 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 11 sources.
The bottom line
Evidence rating strong. Most-documented uses: relieves allergic rhinitis symptoms (sneezing, itching, rhinorrhea), treats chronic idiopathic urticaria, minimal sedation (less than cetirizine). 11 sources indexed (1998–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
A long-acting selective peripheral H1 receptor antagonist. Competitively blocks H1 histamine receptors on target cells, preventing the vasodilatory, permeability-enhancing, and pruritic effects of histamine released during allergic reactions. Also inhibits histamine release from mast cells. At therapeutic doses, loratadine does not significantly cross the blood-brain barrier (P-glycoprotein substrate), resulting in minimal CNS sedation and no significant anticholinergic effects.
Dosing & protocol.
Rapidly absorbed; food delays absorption by approximately 1 hour but does not affect total bioavailability. Can be taken with or without food. Extensively metabolized by CYP3A4 and CYP2D6 to active metabolite desloratadine.
Full safety detail.
Side effects
- Headache
- Drowsiness (uncommon, near placebo rates)
- Fatigue
- Dry mouth
- Nervousness (children)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
3- 1A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitisPMIDWang H, Ji Q, Liao C et al. · Frontiers in pharmacology · 2023
Wang H, Ji Q, Liao C et al.. A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitis. Frontiers in pharmacology. 2023
- 2The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysisPMIDMösges R, König V, Köberlein J · Allergology international : official journal of the Japanese Society of Allergology · 2011
Mösges R, König V, Köberlein J. The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysis. Allergology international : official journal of the Japanese Society of Allergology. 2011
- 3Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysisPMIDSchwarz EB, Moretti ME, Nayak S et al. · Drug safety · 2008
Schwarz EB, Moretti ME, Nayak S et al.. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis. Drug safety. 2008
Randomized controlled trials
3- 4Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitisPMIDNayak AS, Berger WE, LaForce CF et al. · Allergy and asthma proceedings · 2017
Nayak AS, Berger WE, LaForce CF et al.. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. Allergy and asthma proceedings. 2017
- 5Loratadine in the treatment of chronic urticaria: a systematic review and meta-analysisSource linkedPMIDSharma M, Bennett C, Cohen SN, Carter B · Clin Exp Dermatol · 2014
- 6Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitisPMIDKaiser HB, Banov CH, Berkowitz RR et al. · American journal of therapeutics · 1998
Kaiser HB, Banov CH, Berkowitz RR et al.. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis. American journal of therapeutics. 1998
Reviews & position papers
1- 7Efficacy and safety of combined loratadine and mometasone furoate therapy in allergic rhinitis patientsPMIDYong H, Di L, Wang Z et al. · Frontiers in immunology · 2025
Yong H, Di L, Wang Z et al.. Efficacy and safety of combined loratadine and mometasone furoate therapy in allergic rhinitis patients. Frontiers in immunology. 2025
Reference material
4- 8Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004.Source linkedPMID
- 9Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy. 2008.Source linkedPMID
- 10van Cauwenberge P et al. Consensus statement on the treatment of allergic rhinitis. Allergy. 2000.Source linkedPMID
- 11Yamprasert R, Chanvimalueng W, Mukkasombut N et al.. Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial. BMC complementary medicine and therapies. 2020Source linkedPMID
Common questions.
Quick answers about Loratadine, drawn from the data on this page.
What is Loratadine?
A second-generation antihistamine with minimal sedative effects, used for the symptomatic relief of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. One of the least sedating oral antihistamines due to very limited CNS penetration. Available over-the-counter and widely used for its favorable tolerability profile. Active metabolite desloratadine (Clarinex) is also marketed separately.
What is Loratadine used for?
Commonly cited benefits of Loratadine include: Relieves allergic rhinitis symptoms (sneezing, itching, rhinorrhea); Treats chronic idiopathic urticaria; Minimal sedation (less than cetirizine); Once-daily dosing; Available over-the-counter. NutriStack rates the overall evidence as strong.
What is a typical dose of Loratadine?
A typical adult dose of Loratadine is Adults and children >=6 years: 10 mg once daily; children 2-5 years: 5 mg once daily (as prescribed by your physician). The commonly recommended form is Oral tablets, orally disintegrating tablets (Reditabs), or liquid syrup. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Loratadine?
Reported side effects include headache, drowsiness (uncommon, near placebo rates), fatigue, dry mouth, nervousness (children). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Loratadine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Loratadine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.